SBC Medical Group Holdings Incorporated closed at $5.02 on Nov 5, down 5.64%, 11.8% below its 52-week closing high. Volume of 182.1K shares was 1.04× its 20-day average (close to normal).
Split-adjusted performance: -6.0% over one month, +56.4% over six months, +53.5% over one year.
In the quarter ended Jun 30, 2026, revenue was $49.19M, up 13.4% from a year earlier, with a net margin of 21.7%.
Short interest was 750.8K shares at the Oct 15 settlement, down 7.8% from the prior report (4.1% of float, 3.9 days to cover).